Where
THIS IS AN ONLINE EVENT
ZOOM - link will be sent out the week of the event
Cost
Professionals- $50
Students, Families, Caregivers- $35
Payment Options: Visa/Mastercard, PayPal, Cheque
Visa, Mastercard, PayPal: When confirming your registration, you will be taken to the PayPal website to process your payment details.
Cheques: Please make cheques out to VOCPRI, and mail to: VOCPRI c/o Michelle Langdon, 600 Sanatorium Rd, London, N6H 3W7, along with a printout of your e-mail confirmation.
Accreditation Statement:
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University. You may claim a maximum of 2.5 hours (credits are automatically calculated).
This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Schulich School of Medicine & Dentistry, Western University for up to 2.5 Mainpro+ credits.
Each participant should claim only those hours of credit that he/she actually spent participating in the educational program.
The Mainpro+ ID number for this event is: 199185-001
Sponsorship Statement
This program has received an educational grant and in-kind support from The Volunteer Organization of CPRI.
Genetic Testing and Treatment of Interfering Behaviours in Autism Spectrum Disorder
Presented by: Dr. Rob Nicolson, MD, FRCP(C) and Dr. Melissa Carter, MD FRCPC FCCMG
What role does a clinical geneticist play in the evaluation of individuals with autism spectrum disorders? What happens in a genetics clinic? How are parents counselled regarding the chances of having additional children with ASD? What genetic tests are routinely offered to these patients? This presentation is a basic introduction to the field of clinical genetics and the role of clinical geneticists and genetic counsellors, with an emphasis on the genetic evaluation of patients with ASD.
The presentation will also focus on the treatment of interfering behaviours in Autism Spectrum Disorder (Aggression, Inattention, Hyperactivity, Anxiety, etc) and the considerations that arise in children with genetic syndromes.
Learning Objectives:
1. Describe the role of medication in the treatment of interfering behaviours in Autism Spectrum Disorder
2.Review medications that are appropriate for interfering behaviours in Autism Spectrum Disorder
3.Discuss the role of genetic factors in the treatment of interfering behaviours in Autism Spectrum Disorder
About Dr. Rob Nicolson MD, FRCP(C):
Dr. Nicolson is an Associate Professor in the Department of Psychiatry and Chair of the Developmental Disabilities Program at Western University. Dr. Nicolson completed medical school at Western University before moving to The University of Toronto to do his residency in psychiatry. He worked as a visiting scientist in the Child Psychiatry Branch of the National Institute of Mental Health in the United States before returning to London.
Dr. Nicolson is a child psychiatrist whose practice is largely devoted to children and adolescents with Autism Spectrum Disorder and Intellectual Disability. He is a psychiatrist in the Neurodevelopmental Disorders Program at Children’s Hospital at London Health Sciences Centre and in the Autism Spectrum Disorder program at the Child and Parent Resource Institute in London.
Learning Objectives:
- Identify the role of a clinical geneticist in the evaluation of patients with Autism Spectrum Disorder (ASD)
- Examine the reoccurrence risk for Autism
- Examine genetic tests most performed for diagnosis
About Dr. Melissa Carter MD FRCPC FCCMG:
Dr. Carter received an MSc in Molecular Biology in 2001 from Queen’s University and an Medical Doctorate from McMaster University in 2004. She completed residency in Medical Genetics at the University of Ottawa in 2009, followed by a clinical fellowship in Developmental Pediatrics at the University of Toronto. She specializes in the genetic evaluation of individuals with neurodevelopmental disorders. She is the Medical Director of CHEO’s Rett syndrome clinic and also co-directs CHEO’s Angelman syndrome clinic. Her research interests include delineation of the phenotypic consequences of chromosomal anomalies and elucidation of the genetic etiologies of autism spectrum disorder and intellectual disabilities.
Targeted Audience: Allied health professionals, medical professionals, education para-professionals, clinical case managers, front line para-professionals, education professionals.